Social determinants of health and their impact on frontline treatment patterns among Medicare Advantage members with newly diagnosed multiple myeloma
Inequities in timely frontline NDMM treatment were observed for non-White patients and those with DE/LIS status. Combinations of community-level SDoH, but no one single factor, may underlie these inequities.
Authors
- Brandon T. Suehs (ORCID: https://orcid.org/0000-0003-4708-7484)
- K.D. Brunisholz (ORCID: https://orcid.org/0000-0003-0155-6054)
- Alexjandro Daviano
- Yihua Xu (ORCID: https://orcid.org/0000-0003-1445-0638)
- Jennifer S. Harper (ORCID: https://orcid.org/0009-0007-7431-0983)
- Susan Wojcicki
Institutions
- Johnson & Johnson (United States) (US)
- Humana (United States) (US)
Publication Details
- Journal
- Journal of Managed Care & Specialty Pharmacy
- Published
- 2025-05-30
- DOI
- https://doi.org/10.18553/jmcp.2025.31.6.603
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00